Healthcare - Biotechnology - NASDAQ - US
$ 3.47
-12.2 %
$ 247 M
Market Cap
-1.31
P/E
INCOME STATEMENT
0
REVENUE
-249 M
OPERATING INCOME
-292 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Zentalis Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 1.39 M |
| Gross Profit | -1.39 M |
| Operating Expenses | 253 M |
| Operating Income | -249 M |
| Other Expenses | 43.2 M |
| Net Income | -292 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 14 K |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.4 | 1.4 | 0.5 | 0.2 | 0.1 | 0 |
| Gross Profit | (1.4) | (1.4) | (0.5) | (0.2) | (0.1) | 14 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 252.6 | 227.3 | 216.5 | 118.8 | 46.8 | 23.8 |
| Selling, General and Administrative Expenses | 59.4 | 54.6 | 40.9 | 33.9 | 8.5 | 4.9 |
| Research and Development Expenses | 189.6 | 172.7 | 175.6 | 84.9 | 38.4 | 18.9 |
| Operating Income | (249.0) | (227.3) | (216.5) | (118.8) | (46.8) | (23.8) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 2.6 | 0 | 0 | 0 | 0 |
| Total Other Income | (27.9) | 6.0 | 52.0 | 0.7 | 0.5 | 0.4 |
| Pre-Tax Income | (276.9) | (221.3) | (164.6) | (118.1) | (46.4) | (23.4) |
| NET INCOME | ||||||
| Tax Provision | (0.6) | (0.5) | (0.3) | 0.4 | 15 K | 4 K |
| Net Income | (292.2) | (220.8) | (164.3) | (118.5) | (46.4) | (21.1) |
| EPS | 4.47 | 4.18 | 3.85 | 2.89 | 1.29 | 1.17 |